The purpose of this study is to see if it is safe and effective to give saquinavir (as a soft gel capsule taken by mouth) along with 2 other anti-HIV drugs to HIV-infected patients.
Prior to initiation of study treatment all patients are screened and baseline lab values are taken. Patients then receive the study treatment, FORTOVASE, two times a day plus 2 new NRTI's. Assessments will be performed at specified intervals throughout the duration of treatment.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
NONE
Enrollment
80
ASC Inc
Hobson City, Alabama, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dean Martin
Phoenix, Arizona, United States
Wilbert Jordan
Paramount, California, United States
Whitman Walker Clinic
Washington D.C., District of Columbia, United States
Duval County Health Department
Jacksonville, Florida, United States
Ctr for Quality Care
Tampa, Florida, United States
NTouch Research Corp
Decatur, Georgia, United States
Univ of Illinois Hosp at Chicago
Chicago, Illinois, United States
Univ of Kentucky
Lexington, Kentucky, United States
C100 HIV Outpatient Program
New Orleans, Louisiana, United States
...and 12 more locations